Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumie Igari

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|May 26, 2022
The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patientsFumie Igari, Hisashi Tanaka, Armando E Giuliano
Human Pathology|November 11, 2017
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinomaFumie Igari, Eiichi Sato, Yoshiya Horimoto, et al.
BMC Cancer|July 31, 2014
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancerYoshiya Horimoto, Atsushi Arakawa, Masahiko Tanabe, et al.
Research Square|January 23, 2024
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAHisashi Tanaka, Michael Murata, Fumie Igari, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAMichael M Murata, Fumie Igari, Ryan Urbanowicz, et al.
Journal of Clinical Pathology|June 11, 2015
Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patientsYoshiya Horimoto, Atsushi Arakawa, Masahiko Tanabe, et al.
Nucleic Acids Research|December 8, 2020
The fragility of a structurally diverse duplication block triggers recurrent genomic amplificationRyusuke Suzuki, Michael M Murata, Nicholas Manguso, et al.
Journal of Translational Medicine|February 7, 2020
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse modelHideki Furuya, Kazukuni Hayashi, Yoshiko Shimizu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|May 26, 2022
The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patientsFumie Igari, Hisashi Tanaka, Armando E Giuliano
Human Pathology|November 11, 2017
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinomaFumie Igari, Eiichi Sato, Yoshiya Horimoto, et al.
BMC Cancer|July 31, 2014
Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancerYoshiya Horimoto, Atsushi Arakawa, Masahiko Tanabe, et al.
Research Square|January 23, 2024
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAHisashi Tanaka, Michael Murata, Fumie Igari, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAMichael M Murata, Fumie Igari, Ryan Urbanowicz, et al.
Journal of Clinical Pathology|June 11, 2015
Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patientsYoshiya Horimoto, Atsushi Arakawa, Masahiko Tanabe, et al.
Nucleic Acids Research|December 8, 2020
The fragility of a structurally diverse duplication block triggers recurrent genomic amplificationRyusuke Suzuki, Michael M Murata, Nicholas Manguso, et al.
Journal of Translational Medicine|February 7, 2020
Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse modelHideki Furuya, Kazukuni Hayashi, Yoshiko Shimizu, et al.
Pageof 1